Finance

Beta
Lists
SUDEEPPHRM:NSE
Sudeep Pharma Ltd
₹862.00
-2.42%
(-21.35) 1D
Jul 17, 3:30:03 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SUDEEPPHRM...
Open
₹883.00
High
₹894.95
Low
₹857.10
Mkt. cap
97.36B
Avg. vol.
279.28K
Volume
151.57K
Dividend
0.17%
Quarterly dividend
₹0.38
Ex-dividend date
Jul 23, 2026
P/E ratio
55.61
52-wk high
₹894.95
52-wk low
₹524.05
EPS
₹15.50
No. of employees
525
Open
₹883.00
High
₹894.95
Low
₹857.10
Mkt. cap
97.36B
Avg. vol.
279.28K
Volume
151.57K
Dividend
0.17%
Quarterly dividend
₹0.38
Ex-dividend date
Jul 23, 2026
P/E ratio
55.61
52-wk high
₹894.95
52-wk low
₹524.05
EPS
₹15.50
No. of employees
525
News stories
From sources across the web
About Sudeep Pharma Ltd
CEO-
Employees525
Founded1989
Headquarters-
SectorSpeciality chemicals
Websitesudeeppharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.25B
1.63B
1.72B
1.82B
Cost of goods sold
431.01M
609.35M
601.93M
674.88M
Cost of revenue
431.01M
609.35M
601.93M
674.88M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143.25M
140.95M
150.37M
153.34M
Operating expense
411.94M
500.81M
560.33M
561.40M
Total operating expenses
842.95M
1.11B
1.16B
1.24B
Operating income
406.23M
516.50M
561.10M
587.11M
Other non operating income
-1.19M
101.66M
68.37M
-224.91M
EBT including unusual items
440.71M
595.34M
617.76M
626.93M
EBT excluding unusual items
440.69M
595.34M
617.76M
616.16M
Income tax expense
128.02M
127.56M
140.77M
141.55M
Effective tax rate
29.05%
21.43%
22.79%
22.58%
Other operating expenses
236.17M
321.74M
371.34M
366.92M
Net income
308.07M
457.47M
474.62M
488.77M
Net profit margin
24.66%
28.12%
27.54%
26.81%
Earnings per share
-
-
-
4.38
Interest and investment income
170.00K
-
-
33.79M
Interest expense
-15.52M
-22.82M
-11.71M
-19.39M
Net interest expenses
-15.35M
-22.82M
-11.71M
14.40M
Depreciation and amortization charges
32.52M
38.11M
38.61M
38.84M
EBITDA
436.42M
556.94M
601.54M
621.58M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer